We are live on ! Find out more
DGX icon

Quest Diagnostics

1,142 hedge funds and large institutions have $23.9B invested in Quest Diagnostics in 2026 Q3 according to their latest regulatory filings, with 136 funds opening new positions, 382 increasing their positions, 405 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 136 | Existing positions closed: 87

2% more funds holding

Funds holding: 1,119 → 1,142 (+23)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less repeat investments, than reductions

Existing positions increased: 382 | Existing positions reduced: 405

1.97% less ownership

Funds ownership: 95.01% → 93.04% (-2%)

18% less capital inflows, than outflows

Capital inflows: $1.72B | Capital outflows: $2.1B

34% less call options, than puts

Call options by funds: $93.3M | Put options by funds: $140M

Holders
1,142
Holders Change
+23
Holders Change %
+2.06%
% of All Funds
13.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
136
Increased
382
Reduced
405
Closed
87
Calls
$93.3​M
Puts
$140​M
Net Calls
-⁠$47.2​M
Net Calls Change
-⁠$82​M

DGX Hedge Fund Activity: Q3 2026 in Review

1,142 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2026, worth a combined $23.9B — up 7.5% from $22.3B a quarter earlier.

Buyers outnumbered sellers: 136 funds opened new DGX positions and 87 closed out — a net gain of 49 holders — while 382 added to existing stakes and 405 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $720M. The largest seller was JP Morgan Chase, cutting an estimated $146M.

  • 1,142 institutional investors held Quest Diagnostics (DGX) as of Q3 2026, up from 1,119 in Q2 2026.
  • Funds reported $23.9B of Quest Diagnostics stock for Q3 2026, up 7.5% quarter-over-quarter.
  • 136 funds opened new Quest Diagnostics positions in Q3 2026 and 87 closed out, a net change of +49 holders.
  • The largest Quest Diagnostics buyer in Q3 2026 was Fidelity Investments, an estimated $720M added.
  • The largest Quest Diagnostics seller in Q3 2026 was JP Morgan Chase, an estimated $146M sold.

Based on aggregated 13F filings for Q3 2026.